|
Mukaddes
Esrefoglu, Mehmet Gul,
Department of Histology and Embryology, Faculty of Medicine, Inonu
University, 44280 Malatya, Turkey
Memet Hanifi Emre, Alaattin Polat, Department of Physiology,
Faculty of Medicine, Inonu University, 44280 Malatya, Turkey
Mukadder Ayse Selimoglu, Department of Pediatric
Gastroenterology, Hepatology and Nutrition, Faculty of Medicine,
Ataturk University, Erzurum, Turkey
Co-first-authors: Mukaddes Esrefoglu
Co-correspondents: Mukaddes Esrefoglu, Mehmet Gul
Correspondence to: Dr.
Mukaddes Esrefoglu, inonu Universitesi, Tlp Fakultesi,
Histoloji ve Embriyoloji Anabilim Dall, 44128 Malatya, Turkey.
drmukaddes@hotmail.com
Telephone: +90-422-3410660
Fax: +90-422-3410036
Received: 2004-10-23
Accepted: 2004-11-29
Abstract
Aim:
To investigate the role of oxidative injury and the effect of
exogenous melatonin administration on liver damage induced by bile
duct ligation (BDL), and second, to evaluate the role of nitric
oxide (NO), a free oxygen radical, in oxidative injury.
Methods:
Thirty-two Sprague-Dawley rats were assigned to four groups: sham
operation (SO), BDL, BDL+melatonin, and BDL+vehicle. Cholestasis was
achieved by double ligature of the common bile duct. Melatonin was
injected intraperitoneally 500 mg/(kg/d)
for 8 d. Hepatic oxidative stress markers were evaluated by changes
in the amount of lipid peroxides, measured as malondialdehyde (MDA),
and reduced GSH. Total nitrite (NOX)
concentrations were determined in hepatic homogenates.
Histopathological examination was performed using a histological
scoring system.
Results: The
histopathological changes including portal inflammation, necrosis,
apoptosis, focal inflammation and fibrosis were severe in the BDL
and BDL+vehicle groups. There were numerous large areas of
coagulation necrosis. Histological Activity Index scores of these
groups were significantly higher than that of the SO group.
Treatment with melatonin reduced these alterations significantly.
The degree of necro-inflammation and fibrosis showed significant
difference between the BDL and BDL+melatonin groups. BDL was
accompanied by a significant increase in MDA and NOX,
and a significant decrease in GSH levels. Mean±SE
values of MDA, GSH and NOX
levels of SO group were 147.47±6.69,
0.88±0.33
mmol/g
and 180.70±6.58
nm/g, respectively. The values of BDL group were 200.14±21.30,
0.65±0.02
mmol/g,
and 400.46±48.89
nm/g, respectively, whereas the values of BDL+melatonin group were
115.93±6.8,
0.74±0.02
mmol/g,
and 290.38±32.32
nm/g, respectively. Melatonin treatment was associated with a
significant recovery of MDA, GSH and NOX
levels.
Conclusion: We
have concluded that oxidative stress is associated with the
pathogenesis of cholestatic liver damage and NO contributes to
oxidative damage. Melatonin, even at low dose, is an efficient agent
in reducing negative parameters of cholestasis.
ã 2005
The WJG Press and Elsevier Inc. All rights reserved.
Key words: Cholestasis; Melatonin; Oxidative stress; Free
radicals; Hepatic injury
Esrefoglu M, Gul
M, Emre MH, Polat A, Selimoglu
MA. Protective effect of low dose of melatonin against cholestatic
oxidative stress after common bile duct ligation in rats. World J
Gastroenterol 2005;
11(13): 1951-1956
http://www.wjgnet.com/1007-9327/11/1951.asp
INTRODUCTION
Cholestasis, extrahepatic or intrahepatic, is a common
pathophysiological process in many human diseases leading to the
accumulation of toxic bile salts within the liver[1-5].
It seems likely that the detergent action of bile salts is
responsible for solubilization of plasma membranes and cell death,
which in turn may lead to oxidative stress, oxidation of reduced
glutathione (GSH), and lipid peroxidation[6].
There is growing evidence suggesting that considerable impairment of
oxidative stress regulation may play an important role in
cholestatic liver injury[7-11].
Acute bile-duct obstruction is characterized by increased lipid
peroxidation and by marked decline in reduced GSH, a major cellular
antioxidant[12].
It is known that bile-duct ligation (BDL) results in a shift in the
oxidant/prooxidant balance in favor of increased free radical
activity[12,13].
Enhanced production of reactive oxygen intermediates augments lipid
peroxidation by disturbing oxidant-antioxidant balance in hepatic
mitochondrial fraction. The damage pattern of free radicals
interfering with hepatocytes suggests peroxynitrite-mediated liver
injury[14].
As a reactive-free radical, NO mediates the cytotoxicity caused by
activated neutrophils and macrophages in the inflammatory response[15,16].
In attempting to limit the oxidative damage, a
number of antioxidants have been tested in experimental bile-duct
obstruction models[6,7,12].
It has been proposed that antioxidants, which maintain the
concentration of reduced GSH, may restore the cellular defense
mechanism and block lipid peroxidation[10].
Melatonin has been proved to have the greatest impact not only on
oxidative stress, but also on systems of defense against free
radicals, restoring the oxidative balance in treated experimental
animals[10,12].
Administration of melatonin at pharmacological doses has been shown
to decrease free radical formation and lead to a substantial
recovery of the major antioxidant enzymes, thus limiting oxidative
damage to the liver[12].
Recent evidences have shown that melatonin has protective effects on
hepatic injury after extrahepatic BDL in rats[10,11,17].
The aims of this study were first to investigate
the role of oxidative injury and the effect of exogenous melatonin
administration on liver damage induced by BDL, and second, to
evaluate the role of NO in oxidative injury. Hepatic oxidative
stress markers were evaluated by changes in the amount of lipid
peroxides, measured as MDA and GSH. Since NO measurement is
difficult in biological specimens, tissue nitrite (NO2)
and nitrate (NO3)
were estimated as an index of NO production. Additionally, a
detailed histopathological examination using a histological scoring
system was performed. To our knowledge, there has been only one
study revealing histological results about the effects of melatonin
on experimental cholestatic liver injury in rats[17].
We suggest that NO contributes to oxidative stress and melatonin is
a possible protective agent in biliary cholestasis and
parenchymatous liver injury.
MATERIALS AND METHODS
Animals and experimental groups
Thirty-two adult male Sprague-Dawley rats weighing 250-290 g were
used. Animals were housed under continuous observation in
appropriate cages in a quiet temperature (21±2
℃)
and humidity (60±5%)-controlled
room in which a 12-12 h light-dark cycle was maintained. They were
allowed free access to a commercial standard diet and water ad
libitum. Rats were randomly assigned to four groups each containing
eight rats as follows: sham operation (SO) (control), BDL,
BDL+melatonin and BDL+vehicle. Sham-operated rats served as
controls. Except in this group, biliary canals were ligated. Rats
were fasted for 12 h before the operation, but were given water.
Animal experiments were performed in accordance
with the guidelines for animal research from the National Institute
of Health and were approved by the Committee of Animal Research at
Inonu University, Malatya, Turkey.
Surgery procedure
Each rat was weighed and anesthetized by intraperitoneal
administration of ketamin (70 mg/kg) and xylacaine (7 mg/kg). The
abdomen was shaved and disinfected with 10% povidone iodine.
Following a midline incision, the common bile duct was exposed and a
double ligature with 3/0 silk was performed and the bile duct was
sectioned between the ligatures. Abdominal muscles were closed with
3/0 silk and abdominal skin was closed with 2/0 silk. Sham surgery
was identical to the ligation procedure, including locating and
manipulating the common hepatic duct, except that the bile duct was
not ligated or sectioned. Rats were maintained on the retrospective
preoperative diet after surgery. Melatonin (Sigma Chemical Co., St.
Louis, MO) 500 mg/(kg.d)
was dissolved in ethanol and further diluted in saline (0.9 mL/L
NaCl) to give final concentration of 1%. It was given
intraperitoneally at 10.00
a.m. daily, beginning 1 d before the
operation and continuing for seven successive days. BDL+vehicle
group received equal volume (1 mL) of diluted ethanol in saline (0.9
mL/L NaCl). Rats were killed on the 8th
d after the surgery. After the macroscopic findings were noted, the
livers were promptly removed and were processed for histological and
biochemical examination. The right lobe of the liver was divided
into two pieces. The first samples were placed in 40 g/L
formaldehyde for histopathological examination by light microscopy.
The second piece of liver tissues was washed thrice with cold saline
solution, placed into glass bottles, labeled, and stored in a deep
freeze (-85 ℃)
for MDA, NO, and GSH analyses.
Histological examination
Liver tissues were fixed in 40 g/L formaldehyde and were embedded in
paraffin. For histopathological evaluation, 4-mm slides were stained
with hematoxylin-eosin, Masson's
trichrom, Periodic acid-Schiff
(PAS), and Hall's
stain for bile. Sections were
scored by an independent observer blinded to the experimental
protocol. The following lesions were scored according to Modified
Histological Activity Index (HAI):[18,19]
portal inflammation, focal necrosis, confluent necrosis, piecemeal
necrosis, apoptosis, focal inflammation and fibrosis. The number of
biliary canals in five portal sites for each section was also noted.
Biochemical determination
Tissues were homogenized in four volumes of ice-cold Tris-HCl buffer
(50 mmol/L, pH 7.4) using a homogenizer (IKA-Werke Ultra-Turrax T25
basic homogenizer, Germany) after cutting of the liver into small
pieces. The malondialdehyde (MDA), nitric oxide (NO) and reduced GSH
content of homogenates were determined spectrophotometrically.
Assessment of lipid peroxide formation
Lipid peroxide was determined calorimetrically in a sample of
the liver homogenates as thiobarbituric acid-reactive substances (TBA-RS)
according to the method of Uchiyama and Mihara[20].
The absorbances of the formed colored product at 520 and 535 nm were
measured and the results were expressed as the difference in
absorbance at the two wavelengths (A535-520).
MDA are expressed as micromole per gram wet hepatic tissue.
NO determination As
NO measurement is very difficult in biological specimens,
tissue nitrite (NO2)
plus nitrate (NO3)
concentrations were estimated as an index of NO production. The
method for tissue NO2
plus NO3 levels
based on the Griess reaction was used[21].
Samples were initially deproteinized with Somogy reagent[22].
Total nitrite (NOX)
(NO2+NO3)
was measured after conversion of nitrate to nitrite by copperized
cadmium granules by a spectrophotometer at 545 nm. Results are
expressed as nanomole per gram wet hepatic tissue.
Reduced glutathione determination Liver tissues were deproteinated by the addition of
trichloroacetic acid. DTNB [5,5-dithiobis(2-nitrobenzoic acid)] was
added to supernatants cleared by centrifugation (10 min, 3 000
r/min). The formation of 5-thio-2-nitrobenzoic acid, which is
proportional to total GSH concentration, was monitored at 412 nm at
25 ℃
against reagent controls[23].
The level of GSH was determined from the standard curve with
commercially available GSH (Sigma Chemical Co.). GSH are expressed
as micromole per gram wet hepatic tissue.
Statistical analysis
The results were statistically analyzed by the Kruskal-Wallis H
test. The differences between groups were evaluated by the
Mann-Whitney U test followed by t test with Bonferroni
correction when indicated. P<0.05 was considered
significant. The results are expressed as the arithmetic mean±SE.
RESULTS
Survival and macroscopic findings
Twenty-four hours after operation, clinical condition of the animals
of all groups except those of the SO group worsened, with decreasing
activity, weight loss, yellowed ears and tails, darkened urine and
pale feces. All of the animals survived until the end of the
experiment. Jaundice was observed in the visceral and parietal
peritoneum of all animals except those of the SO group. The livers
were enlarged and the bile ducts above the obstruction point were
dilated. Animals from the SO group showed no alteration after
surgery and were killed on d 8.
Microscopic findings
Animals from the SO group presented no histological alterations. The
liver specimens of the BDL and BDL+ melatonin groups showed various
degrees of lobular and portal changes. The degree of necro-inflammation
(focal necrosis, confluent necrosis, piecemeal necrosis, focal and
portal inflammation, and apoptosis) and fibrosis showed significant
difference between the BDL and BDL+melatonin groups (P<0.05).
HAI scores of the groups are summarized in Table 1. The
number of bile ducts in five portal sites for each section did not
show significant differences among the BDL, BDL+vehicle and
BDL+melatonin groups. The number of bile ducts is summarized in
Table 2. In the BDL and BDL+vehicle groups the histopathological
changes including necrosis, bile duct proliferation, fibrosis and
polymorphonuclear leukocyte (PNL) and lymphocyte infiltration were
prominent (Figure 1A). There were numerous large areas of
coagulation necrosis randomly distributed. The Masson's
trichrom staining of liver
tissue showed fibrotic reaction that was usually accompanied with
inflammatory cells in the periphery of the majority of the portal
space areas (Figure 1B). Many mitotic figures and apoptotic bodies
were seen. There was a massive loss in the amount of glycogen in
hepatocytes (Figure 1C). Although all of the liver sections were
stained with Hall's
bilirubin pigment staining
technique, no bile pigment accumulation was demonstrated neither in
canaliculi nor in bile ducts.
In the BDL+melatonin group, histopathological evidence of
parenchymatous injury was markedly reduced (Figure 1D). Relatively
small, scattered necrotic hepatocyte groups between normal-appearing
parenchymal cells were observed. Portal fibrosis was not evident
(Figure 1E). Bile duct proliferation (Figure 1E) and glycogen
depletion were still prominent. Apoptotic bodies and mitotic figures
were also observed.
Figure
1 A:
BDL group. Portal fibrosis (f) with bile duct proliferation (thick
arrows) and cell infiltration (arrows), and a large area of
coagulation necrosis (n) are observed. H-E, ×10; B:
BDL group. Portal fibrosis (f) with bile duct proliferation (arrows)
and cell infiltration is observed. Portal vein (p) is highly
enlarged. Masson’s trichrom, ×20; C:BDL
group. A massive loss in the amount of glycogen in hepatocytes is
seen. There are a mitotic figure (arrow) and an apoptotic body
(double arrow) in the parenchyma. PAS, ×40; D:
BDL+melatonin group. Section is normal in histological appearance.
Hepatocytes arranged as cords of cells radiating from central vein
(c) are observed. H-E, ×40; E:
BDL+melatonin group. Portal fibrosis is not evident. Bile duct
proliferation is obvious (arrows). A small area of necrosis (n) is
present between proliferated ducts. Masson’s trichrom, ×20.
Acute ligation of bile duct was accompanied by a significant
increase in MDA and NO, and a significant reduction in GSH levels in
hepatic homogenates. Melatonin administration significantly
decreased MDA and NO levels, whereas significantly increased GSH
levels (P<0.05). MDA, GSH and NOX
concentrations measured in hepatic tissue
are summarized in Table 3.
The histopathological analyses correlated with biochemical data.
Table 1
Scores for necro-inflammation (focal necrosis, confluent
necrosis, piecemeal necrosis, focal and portal inflammation, and
apoptosis) and fibrosis of groups using modified HIA grading system
(mean±SE)
| |
Scores
for necro-inflammation |
Scores
for fibrosis |
| SO |
0.25±0.16 |
0±0 |
| BDL |
11.87±0.83a |
1.37±0.18a |
| BDL+vehicle |
11.12±1.00a |
1.35±0.20a |
| BDL+melatonin |
6.87±0.63c |
0.75±0.25c |
SO: sham operation; BDL: bile
duct ligation; HAI: Histological Activity Index. aP<0.05
vs SO.
cP<0.05
vs BDL,
BDL+vehicle.
Table 2
Number of biliary canals in five portal sites for each
specimen (mean±SE)
| |
Number
of biliary canals |
| SO |
9.37±0.49 |
| BDL |
40.37±2.50a |
| BDL+vehicle |
39.50±2.67a |
| BDL+melatonin |
39.87±2.01a |
SO:
sham operation; BDL: bile duct ligation. aP<0.05
vs SO.
Table
3 MDA,
GSH and NOX
concentrations measured in hepatic tissue
| |
MDA
(µmol/g
tissue) |
GSH
(µmol/g
tissue) |
NOX
(nmol/g tissue) |
| SO |
147.47±6.69 |
0.88±0.03 |
180.70±6.58 |
| BDL |
200.14±21.30a |
0.65±0.02a |
400.46±48.89a |
| BDL+vehicle |
211.12±19.98 |
0.63±0.04a |
411.66±77.32 |
| BDL+melatonin |
115.93±6.80c |
0.74±0.02e |
290.38±32.32e |
SO:
sham operation; BDL: bile duct ligation; MDA: malondialdehyde; GSH:
reduced glutathione; NOX:
NO2
(nitrite)+NO3
(nitrate).
aP
<0.05
vs SO. cP<0.05
vs BDL,
BDL+vehicle. eP<0.05
vs BDL.
DISCUSSION
When a large bile duct is obstructed at any point in its course,
several microscopic changes follow[24].
The morphological features of cholestasis depend on its severity,
duration, and underlying cause[1].
The ducts themselves dilate and are filled with abundant bile[1,24].
Droplets of bile pigments can accumulate within hepatocytes[1].
Within a few days of the onset of obstruction, alterations are found
in the portal tracts. The portal tracts become swollen as a result
of edema of the connective tissue and infiltration by PNL, a
classical acute inflammatory reaction attributed to the action of
toxic bile salts reabsorbed from the bile by small bile ducts[2,24].
The bile stasis and backpressure due to obstruction induce
proliferation of the duct epithelial cells and looping and
reduplication of ducts, termed 'bile
duct proliferation'[1].
If the obstruction is not relieved, increasing fibrosis around ducts
and extending between adjacent portal tracts develops[1,2,24].
Biliary obstruction leads to the death of hepatocytes due to bile
accumulation[2,4].
Hepatic injury and cell death leads ultimately to liver fibrosis,
cirrhosis, and cancer[2].
In the present study, bile duct proliferation in all groups compared
to the controls was a result of the biliary obstruction. The number
of bile ducts in five portal sites for each section did not show
significant differences among the BDL, BDL+vehicle and BDL+melatonin
groups (P>0.05) since obstruction was not relieved.
Abdel-Aziz et al.[25],
observed extensive bile duct proliferation and
formation of periportal fibrosis, with only slight
inflammation and necrosis in their experimental model of
extrahepatic cholestasis in rats. We have observed many
histopathological features of cholestasis such as focal necrosis,
confluent necrosis, piecemeal necrosis, focal and portal
inflammation, bile duct proliferation and fibrosis in our
experimental model. HAI scores of the BDL and BDL+vehicle groups
were significantly higher than that of the SO group. Moreover, the
obstructive jaundice was demonstrated by the coloration of the skin,
peritoneum, and urine, and the dilatation of the common bile duct
above the obstruction point. On the other hand, although bilirubin
is one of the easiest pigments to be identified in standard HE
sections, we could not observe it either in canaliculi or in bile
ducts even though we used Hall's
stain for bile salts. Bile
pigment accumulation within hepatocytes, canaliculi or bile ducts
has been supposed to be one of the characteristic features of
cholestasis[1].
As far as we know, in rodents the absence of bile salts after BDL
has already been reported twice before in the studies of Prado et
al.[4],
and Trauner and Boyer[26].
It is probably due to the induction of alternative
detoxification
and elimination pathways, which is very pronounced in rodents[26].
We think that bile salt accumulation may not accompany the other
characteristic features of cholestasis in rodents.
Cell degeneration and death in cholestasis have been reported to be
related to retention of toxic bile salts[2,4,6].
It seems that the detergent action of bile salts is responsible for
solubilization of plasma membranes and cell death, which in turn may
lead to oxidative stress[6].
It is shown that the acute infusion of toxic bile salts responsible
for cholestasis induces zone 1 hepatocellular necrosis[5].
Padillo et al.[27],
have observed marked necrosis and
apoptosis induced by cholestasis. In the present study, we observed
numerous areas of coagulation necrosis and many apoptotic bodies in
the BDL and BDL+vehicle groups. However, since we have not been able
to identify accumulation of bile salts within parenchyma, we are
suspicious about the direct, inducing role of the bile salts on the
hepatocellular injury after BDL although, we cannot fully exclude
the role of these products. A possible explanation is that an
oxidative stress initiated by bile salts would make hepatocytes more
susceptible to the toxic effects of small amount of bile salts, of
which great amounts have been detoxified, that would not ordinarily
injure the hepatic cells.
We observed many mitotic figures both in hepatocytes and in ductular
epithelial cells. Mitosis and fibrosis within the parenchyma are the
signs of wound repair. Increased cell proliferation and increased
secretion of collagen and the other matrix proteins are important
compensatory mechanisms for the repair of the injured tissues[28].
Mitosis in the ductular epithelium is the evidence of bile duct
proliferation. The bile stasis and backpressure induce proliferation
of the duct epithelial cells[1].
Bulbuller
et al.[17]
observed mitotic figures in parenchyma and proliferation of biliary
canals 7 d after experimental biliary canal obstruction. After
bile-duct obstruction, the deposition of connective tissue elements
and formation of ductular proliferates rapidly set in[29].
In our study, fibrous expansion of most portal areas was observed
but portal to portal bridging was not present. So, HAI score for
fibrosis was relatively low.
In obstructive jaundice, glucose metabolism undergo changes, the
most common being the development of glucose intolerance[17,30].
Recent studies have reported a decrease in serum glucose values[17]
and hepatic glycogen content[31,32].
We have observed nearly a total loss in the amount of glycogen in
hepatocytes. Loss of appetite, reduction of oral food intake,
reduced glycogen synthesis, possibly related to endotoxinemia, may
probably be the causes of decrease in the hepatic glycogen content[17,29,32].
Many studies have reported that there is a correlation between the
intensity of biliary tract obstruction and increased free radical
generation, as well as a direct correlation between the level of
oxidative stress and the biochemical markers of liver injury[6-11,14].
It has been well established that deleterious accumulation of lipid
peroxides is correlated with marked impairment of soluble
antioxidant defense mechanisms and cell necrosis[5,9,14,33].
Acute BDL is associated with an increase in MDA levels and a
decrease in GSH levels both in plasma and in tissue[9,10,17,34-37].
Cruz et al.[37],
have reported an increase in MDA and a
decrease in GSH levels in renal tissue after biliary obstruction. As
observed in previous studies, biliary tract obstruction was
accompanied by increased levels of lipid peroxidation and by the
depletion of GSH, a ubiquitous antioxidant, in hepatic tissue in our
study. On the other hand, there is increasing evidence that the
enhanced production of reactive oxygen intermediates augments lipid
peroxidation by disturbing the oxidant-antioxidant balance in
hepatocytes. Since the levels of NOX
in the liver were significantly higher in
the BDL and BDL+vehicle groups than in the SO group (P<0.05),
we suggest that NO, probably via its derivative peroxynitrite, may
contribute to oxidative damage.
Engin et al.[14],
reported a significant increase in plasma NO2,
NO3 and
NOX
concentrations in inbred albino guinea pigs 24 h after common BDL.
A number of antioxidants have been tested in experimental bile-duct
obstruction models in the attempt to limit the oxidative damage[7,12].
Administration of melatonin at pharmacological doses has been shown
to decrease free radical formation and lead to a substantial
recovery of the major antioxidant enzymes, thus limiting oxidative
damage to the liver[10-12,17].
It is shown that melatonin administration reduces histopathological
signs of liver injury such as focal necrosis and apoptosis[17,27].
There are a few studies about the protective effect of low dose of
melatonin against oxidative stress[27,37].
In the present study, histopathological evidence of parenchymatous
injury was significantly reduced in the BDL+melatonin group (P<0.05).
Portal fibrosis was not evident in this group. Additionally,
melatonin administration prevented the GSH decrease and reduced
significantly lipid peroxidation products. Montilla et al.[10],
reported significant differences in tissue and plasma MDA and GSH
levels between non-treated and low dose of melatonin-treated rats.
Lower levels of hepatic NOX
in the BDL+melatonin group than in the BDL
group (P<0.05) may support the role of melatonin on
reducing free radical generation.
As a conclusion, the present study confirms the association between
hepatic injury and increased oxidative stress, possibly mediated by
NO. We have proved that even low dose of melatonin is efficient
reducing the negative parameters of cholestasis, the degree of
oxidative stress, and provided a significant hepatoprotective effect
against liver injury secondary to ligation of biliary duct. Finally,
we suggest that further studies comparing higher doses of melatonin
should be performed in order to determine if the effect of melatonin
is dose-dependent.
REFERENCES
1 Crawford
JM. The Liver and Biliary Tract. In: Cotran RS, Kumar VK,
Collins TC, eds. Robins Pathologic Basis of
Disease.
Philadelphia: W.B. Saunders 1999: 851-852
2
Oh
SH, Yun KJ, Nan JX, Sohn DH, Lee BH. Changes in expression and
immunolocalization of protein associated with
toxic bile
salts-induced apoptosis in rat hepatocytes. Arch Toxicol
2003; 77: 110-115
3 Miyoshi
H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Hepatocyte
apoptosis after bile duct ligation in mouse involves
Fas. Gatroenterology
1999; 117: 669-677
4
Prado IB, dos Santos MH, Lopasso FP, Iriya K, Laudanna AA. Cholestasis
in a murine model: lesions include
hepatocyte ischemic necrosis. Rev
Hosp Clin 2003; 58: 27-32
5
Schmucker
DL, Ohta M, Kanai S, Sato Y, Kitani K. Hepatic injury
induced by bile salts: correlation between
biochemical and
morphological events. Hepatology 1990; 12: 1216-1221
6
Baron
V, Muriel P. Role of glutathione, lipid peroxidation and
antioxidants on acute bile-duct obstruction in the
rat. Biochim
Biophys Acta 1999; 1472: 173-180
7
Pastor
A, Collado PS, Almar M, Gonzalez-Gallego J. Antioxidant enzyme
status in biliary obstructed rats: effects
of N-acetylcysteine. J
Hepatol 1997; 27: 363-370
8
Orellana
M, Rodrigo R, Thielemann L, Guajardo V. Bile duct
ligation and oxidative stress in rat: effects in liver and
kidney. Comp
Biochem Physiol C Toxicol Pharmacol 2000; 126: 105-111
9
Ljubuncic
P, Tanne Z, Bomzon A. Evidence of systemic phenomenon for
oxidative stress in cholestatic liver disease.
Gut 2000; 47:
710-716
10
Montilla
P, Cruz A, Padillo FJ, Tunez I, Gascon F, Munoz MC, Gomez M,
Pera C. Melatonin versus vitamin E as
protective treatment against
oxidative stress after extra-hepatic bile duct ligation in rats. J
Pineal Res 2001; 31: 138-144
11
Ohta
Y, Kongo M, Kishikawa T. Melatonin exerts a therapeutic effect
on cholestatic liver injury in rats with bile
duct ligation. J
Pineal Res 2003; 34: 119-126
12
Cruz
A, Padillo FJ, Granados J, Tunez I, Munoz MC, Briceno J, Pera
Madrazo C, Montilla C. Effect of melatonin
on cholestatic oxidative
stress under constant light exposure. Cell Biochem Funct
2003; 21: 377-380
13
Alptekin
N, Mehmetcik G, Uysal M, Aykac-toker G. Evidence for
oxidative stress in hepatic mitochondria of bile
duct ligated rats. Pharmacol
Res 1997; 36: 243-247
14
Engin
A, Bozkurt B, Altan N, Memis L, Bukan N. Nitric
oxide-mediated liver injury in the presence of experimental
bile
duct obstruction. World J Surg 2003; 27: 253-255
15
Watanabe
N, Soichiro M, Shigeyuki Z, Ishii H. Heaptocellular
oxidative DNA injury induced by macrophage-derived
nitric oxide. Free
Radic Biol Med 2001; 30: 1019-1028
16
D'Ambrosio
SM, Gibson-D'Ambrosio
RE, Brady T, Oberyszyn AS, Robertson FM. Mechanisms
of nitric
oxide-induced cytotoxicity in normal human hepatocytes. Environ
Mol Mutagen 2001; 37: 46-54
17
Bulbuller
N, Akku
MA, Cetinkaya Z, Ilhan YS, Ozercan
I, Kyrkyr
C, Dogru O. Effects of melatonin
and lactulose on
the liver and kidneys in rats with obstructive
jaundice. Pediatr Surg Int 2002; 18: 677-680
18
Knodell
RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan
TW, Wollman J. Formulation and application
of a numerical scoring
system for assessing histological activity in asymptomatic chronic
active hepatitis.
Hepatology 1981; 1: 431-435
19
Ishak
K, Babtista A, Bianchi L, Callea F, De Groote J, Gudot F, Denk
H, Desmet V, Korb G, MacSween RN, Phillips
MJ, Portmann BG, Poulsen
H, Scheuer PJ, Schmid M, Thaler H. Histological grading and staging
of chronic hepatitis.
J Hepatol 1995; 22: 696-699
20
Uchiyama
M, Mihara M. Determination of malonaldehyde precursors in
tissues by thiobarbituric acid test. Anal
Biochem 1978; 86:
271-278
21
Cortas
NK, Wakid NW. Determination of inorganic nitrate in serum and
urine by a kinetic cadmium-reduction
method. Clin Chem 1990; 36:
1440-1443
22 Somogy
M. A method for the preparation of blood filtrates for the
determination of sugar. J Biol Chem 1930;
86: 655-663
23
Ellman
GL. Tissue sulfhydryl groups. Arch. Biochem Biophys 1959;
8: 70-77
24 Scheuer
PJ. Non-viral causes of inflammation. In: Mc Gee JO扗,
Isaacson PG, Wright NA, eds. Oxford Textbook
of Pathology. Oxford:
Oxford University Press 1992: 1308-1309
25
Abdel-Aziz
G, Lebeau G, Rescan PY, Clement B, Deugnier Y, Campion JP,
Guilliouzo A. Reversibility of hepatic fibrosis
in
experimentally induced cholestasis in rat. Am J Pathol 1990; 137:
1333-1342
26
Trauner
M, Boyer JL. Bile salt transporters: molecular characterization,
function, and regulation. Physiol Rev 2003;
83:
633-671
27
Padillo
FJ, Cruz A, Navarrete C, Bujalance J, Gallardo JI, Marchal T,
Caballero R, Tunez I, Muntane J, Pera-Madrazo
C. Melatonin prevents
oxidative stress and hepatocyte cell death induced by experimental
cholstasis. Free Radic
Res 2004; 38: 697-704
28 Weinbren
K. Hepatocyte hyperplasia. In: Mc Gee JO扗,
Isaacson PG, Wright NA eds. Oxford Textbook of
Pathology. Oxford:
Oxford University Press 1992: 1382
29 Hinz
S, Franke H, Machnik G, Muller A, Dargel R. Histological
and biochemical changes induced by total bile duct
ligation in rat. Exp
Toxicol Pathol 1997; 49: 281-288
30
Krahenbuhl
L, Hagenbuch B, Berardi S, Schafer M, Krahenbuhl S. Rapid
normalization of hepatic glycogen
metabolism in rats with long-term
bile duct ligation after biliodigestive anastomosis. J Hepatol 1999;
31: 656-663
31
Lang
C, Schafer M, Varga L, Zimmermann A, Krahenbuhl S, Krahenbuhl L.
Hepatic and skeletal muscle
glycogen metabolism in rats with
short-term cholestasis. J Hepatol 2002; 36: 22-29
32
Krahenbuhl
L, Talos C, Reichen J, Krahenbuhl S. Progressive decrease in
tissue glycogen content in rats with
long-term cholestasis. Hepatology
1996; 24: 902-907
33
Singh
S, Shackleton G, Ah-Sing E Chakraborty J, Bailey ME. Antioxidant
defenses in the bile duct-ligated
rat. Gastroenterology 1992;
103: 1625-1629
34
Muriel
P, Deheza R. Fibrosis and glycogen stores depletion induced by
prolonged biliary obstruction in the
rat ameliorated by metadoxine. Liver
Int 2003; 23: 262-268
35
Huang
YT, Hsu YC, Chen CJ, Liu CT, Wei YH. Oxidative stress-related
changes in the livers of bile-duct ligated rats.
J Biomed Sci 2003;
10: 170-178
36
Ohta
Y, Kongo M, Kishikawa T. Therapeutic effect of melatonin
on cholestatic liver injury in rats with bile duct
ligation. Adv
Exp Med Biol 2003; 527: 559-565
37 Cruz
A, Padillo FJ, Tunez I, Munoz C, Granados J, Pera-Madrazo C,
Montilla P. Melatonin protects against renal
oxidative stress after
obstructive jaundice in rats. Eur J Pharmacol 2001; 425:
135-139
Science Editor Guo SY Language Editor Elsevier HK
| |